141 related articles for article (PubMed ID: 12204003)
1. Analysis of the PTCH coding region in human rhabdomyosarcoma.
Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H
Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003
[TBL] [Abstract][Full Text] [Related]
2. Unbalanced overexpression of the mutant allele in murine Patched mutants.
Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.
Tostar U; Malm CJ; Meis-Kindblom JM; Kindblom LG; Toftgård R; Undén AB
J Pathol; 2006 Jan; 208(1):17-25. PubMed ID: 16294371
[TBL] [Abstract][Full Text] [Related]
4. Sporadic medulloblastomas contain PTCH mutations.
Raffel C; Jenkins RB; Frederick L; Hebrink D; Alderete B; Fults DW; James CD
Cancer Res; 1997 Mar; 57(5):842-5. PubMed ID: 9041183
[TBL] [Abstract][Full Text] [Related]
5. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.
Zurawel RH; Allen C; Chiappa S; Cato W; Biegel J; Cogen P; de Sauvage F; Raffel C
Genes Chromosomes Cancer; 2000 Jan; 27(1):44-51. PubMed ID: 10564585
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the human homologue of Drosophila patched in Japanese nevoid basal cell carcinoma syndrome patients.
Fujii K; Kohno Y; Sugita K; Nakamura M; Moroi Y; Urabe K; Furue M; Yamada M; Miyashita T
Hum Mutat; 2003 Apr; 21(4):451-2. PubMed ID: 12655573
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation.
Unden AB; Holmberg E; Lundh-Rozell B; Stähle-Bäckdahl M; Zaphiropoulos PG; Toftgård R; Vorechovsky I
Cancer Res; 1996 Oct; 56(20):4562-5. PubMed ID: 8840960
[TBL] [Abstract][Full Text] [Related]
8. UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype.
Heitzer E; Lassacher A; Quehenberger F; Kerl H; Wolf P
J Invest Dermatol; 2007 Dec; 127(12):2872-81. PubMed ID: 17597822
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of patched mutations in a collection of Australian basal cell carcinomas.
Evans T; Boonchai W; Shanley S; Smyth I; Gillies S; Georgas K; Wainwright B; Chenevix-Trench G; Wicking C
Hum Mutat; 2000; 16(1):43-8. PubMed ID: 10874304
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
[TBL] [Abstract][Full Text] [Related]
12. Identification of PATCHED mutations in medulloblastomas by direct sequencing.
Dong J; Gailani MR; Pomeroy SL; Reardon D; Bale AE
Hum Mutat; 2000 Jul; 16(1):89-90. PubMed ID: 10874314
[TBL] [Abstract][Full Text] [Related]
13. PTCH gene mutations in odontogenic keratocysts.
Barreto DC; Gomez RS; Bale AE; Boson WL; De Marco L
J Dent Res; 2000 Jun; 79(6):1418-22. PubMed ID: 10890722
[TBL] [Abstract][Full Text] [Related]
14. Involvement of patched (PTCH) gene in Gorlin syndrome and related disorders: three family cases.
Situm M; Levanat S; Crnic I; Pavelic B; Macan D; Grgurević J; Mubrin-Koncar M; Lipozencić J
Croat Med J; 1999 Dec; 40(4):533-8. PubMed ID: 10554356
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32.
Smyth I; Narang MA; Evans T; Heimann C; Nakamura Y; Chenevix-Trench G; Pietsch T; Wicking C; Wainwright BJ
Hum Mol Genet; 1999 Feb; 8(2):291-7. PubMed ID: 9931336
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations of the PTCH gene in Japanese patients with nevoid basal cell carcinoma syndrome.
Tanioka M; Takahashi K; Kawabata T; Kosugi S; Murakami K; Miyachi Y; Nishigori C; Iizuka T
Arch Dermatol Res; 2005 Jan; 296(7):303-8. PubMed ID: 15565302
[TBL] [Abstract][Full Text] [Related]
17. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.
Soufir N; Gerard B; Portela M; Brice A; Liboutet M; Saiag P; Descamps V; Kerob D; Wolkenstein P; Gorin I; Lebbe C; Dupin N; Crickx B; Basset-Seguin N; Grandchamp B
Br J Cancer; 2006 Aug; 95(4):548-53. PubMed ID: 16909134
[TBL] [Abstract][Full Text] [Related]
18. Contributions of PTCH gene variants to isolated cleft lip and palate.
Mansilla MA; Cooper ME; Goldstein T; Castilla EE; Lopez Camelo JS; Marazita ML; Murray JC
Cleft Palate Craniofac J; 2006 Jan; 43(1):21-9. PubMed ID: 16405370
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mutation in exon 17 of PTCH in patients with nevoid basal cell carcinoma syndrome.
Li J; Wang J; Liu Y; Wang W
Mol Biol Rep; 2010 Jan; 37(1):359-62. PubMed ID: 19728145
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
